Literature DB >> 714829

Renal osteodystrophy in end-stage renal failure.

D F Nortman, J W Coburn.   

Abstract

Renal osteodystrophy has many skeletal pathologic features, eg, fibroosteoclasia (osteitis fibrosa), osteomalacia, osteopenia, pseudofracture, cyst formation, and osteosclerosis. Many of these are caused by the secondary hyperparathyroidism that usually accompanies renal failure. Derangements in parathyroid hormone secretion, calcium and phosphate metabolism, and renal production of 1,25-dihydroxycholecalciferol (the most active form of vitamin D) are all interrelated and pathogenetic features of renal osteodystrophy. Types of abnormalities detected radiologically vary with patient age, type of management, and duration of hemodialysis, as well as with techniques and type of film used and interest of the radiologist. An x-ray film of the hands should always be made--it will show subperiosteal resorption in a large number of patients on dialysis. Prevention and management of renal osteodystrophy hinge on control of hyperphosphatemia and hypocalcemia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 714829     DOI: 10.1080/00325481.1978.11714976

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  3 in total

1.  Leontiasis ossea, flail chest and pancytopenia in a patient with renal osteodystrophy.

Authors:  D B Hogan; R A Couture; D Z Levine
Journal:  Can Med Assoc J       Date:  1982-11-15       Impact factor: 8.262

2.  Chronic renal failure-induced changes in serum and urine bile acid profiles.

Authors:  F Jimenez; M J Monte; M Y El-Mir; M J Pascual; J J G Marin
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

3.  Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease.

Authors:  Kathleen M Hill; Berdine R Martin; Meryl E Wastney; George P McCabe; Sharon M Moe; Connie M Weaver; Munro Peacock
Journal:  Kidney Int       Date:  2012-12-19       Impact factor: 10.612

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.